Formula: | C20H29N3O5 |
Molecular Weight: | 391.47 |
Rotatable Bond Donors: | 6 |
clogP: | 1.59 |
Topological Polar Surface Area: | 81.20 |
Lipinski's RO5: | MW: 391.47 HBA: 8 HBD: 0 RB: 6 LogP: 1.59 |
Rule of Three: | MW: 391.47 HBA: 8 HBD: 0 RB: 6 LogP: 1.59 |
|
ECBD ID | Similarity | Structure | SDF |
---|
ECBD ID | Similarity | Structure | SDF | |
---|---|---|---|---|
EOS31773 | 0.7 | EOS31773 RDKit 3D 27 29 0 0 0 0 0 0 0 0999 V2000 7.0513 -0.2980 1.0398 C 0 0 0 0 0 0 0 0 0 0 0 0 6.2280 -1.4457 0.8689 O 0 0 0 0 0 0 0 0 0 0 0 0 5.0067 -1.1197 0.3470 C 0 0 0 0 0 0 0 0 0 0 0 0 4.6045 0.1886 0.0758 C 0 0 0 0 0 0 0 0 0 0 0 0 3.3401 0.4422 -0.4520 C 0 0 0 0 0 0 0 0 0 0 0 0 2.4609 -0.6124 -0.6956 C 0 0 0 0 0 0 0 0 0 0 0 0 1.1423 -0.3891 -1.3227 C 0 0 0 0 0 0 0 0 0 0 0 0 0.7097 -1.2494 -2.0858 O 0 0 0 0 0 0 0 0 0 0 0 0 0.4385 0.7682 -1.0310 N 0 0 0 0 0 0 0 0 0 0 0 0 0.7437 1.6469 0.0789 C 0 0 0 0 0 0 0 0 0 0 0 0 -0.4134 1.6765 1.0545 C 0 0 0 0 0 0 0 0 0 0 0 0 -1.7087 2.0933 0.3865 C 0 0 0 0 0 0 0 0 0 0 0 0 -2.8475 1.2825 0.9505 C 0 0 1 0 0 0 0 0 0 0 0 0 -4.3146 1.6799 0.6539 C 0 0 1 0 0 0 0 0 0 0 0 0 -4.5680 2.6919 -0.3449 O 0 0 0 0 0 0 0 0 0 0 0 0 -5.9316 2.7536 -0.7388 C 0 0 0 0 0 0 0 0 0 0 0 0 -4.4550 0.2010 0.2045 C 0 0 0 0 0 0 0 0 0 0 0 0 -5.3639 -0.5617 -0.0279 O 0 0 0 0 0 0 0 0 0 0 0 0 -3.1026 0.0228 0.2409 N 0 0 0 0 0 0 0 0 0 0 0 0 -2.4498 -1.2306 0.5080 C 0 0 0 0 0 0 0 0 0 0 0 0 -2.8655 -1.8248 1.8340 C 0 0 0 0 0 0 0 0 0 0 0 0 -2.6870 -2.2266 -0.6001 C 0 0 0 0 0 0 0 0 0 0 0 0 -1.6448 2.0974 -1.1295 C 0 0 0 0 0 0 0 0 0 0 0 0 -0.8388 0.9415 -1.6922 C 0 0 0 0 0 0 0 0 0 0 0 0 2.8588 -1.9257 -0.4470 C 0 0 0 0 0 0 0 0 0 0 0 0 4.1228 -2.1682 0.0811 C 0 0 0 0 0 0 0 0 0 0 0 0 4.4838 -3.4344 0.3371 F 0 0 0 0 0 0 0 0 0 0 0 0 1 2 1 0 2 3 1 0 3 4 2 0 4 5 1 0 5 6 2 0 6 7 1 0 7 8 2 0 7 9 1 0 9 10 1 0 10 11 1 0 11 12 1 0 13 12 1 6 13 14 1 0 14 15 1 6 15 16 1 0 14 17 1 0 17 18 2 0 17 19 1 0 19 20 1 0 20 21 1 0 20 22 1 0 12 23 1 0 23 24 1 0 6 25 1 0 25 26 2 0 26 27 1 0 26 3 1 0 24 9 1 0 19 13 1 0 M END $$$$ |
Name | Assay stage | Target | Activity |
---|---|---|---|
GPR35 antagonism | primary assay | G-protein coupled receptor 35 | inactive |